[1] Abstract LBA2_PR – ?Use of G-CSF and prophylactic antibiotics with concurrent chemo-radiotherapy in limited-stage small cell lung cancer: results from the phase III CONVERT trial,? will be presented by Dr Fabio Gomes during the Proffered Paper session ?SCLC and early stage NSCLC? on Sunday, 7 May, 09:00 (CEST).
[2] Smith TJ, et al. Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2015;33(28): 3199?3212.
[3] Bunn PA Jr, et al. Chemoradiotherapy with or without granulocyte-macrophage colony-stimulating factor in the treatment of limited-stage small-cell lung cancer: a prospective phase III randomized study of the Southwest Oncology Group. J Clin Oncol. 1995;13(7):1632?1641.
Home Abstract LBA2_PR – ?Use of G-CSF and prophylactic antibiotics
